The gene therapy watchers: Can an NIH advisory committee reinvent itself?
Francis Collins, NIH Director, and Scott Gottlieb, FDA Commissioner, recently announced plans to eliminate oversight of new gene therapy experiments by the NIH’s Recombinant DNA
Read more